Jump to ContentJump to Main Navigation
Prescription for ChangeThe Looming Crisis in Drug Development$
Users without a subscription are not able to see the full content.

Michael Kinch

Print publication date: 2016

Print ISBN-13: 9781469630625

Published to North Carolina Scholarship Online: May 2017

DOI: 10.5149/northcarolina/9781469630625.001.0001

Show Summary Details
Page of

PRINTED FROM UNIVERSITY OF NORTH CAROLINA PRESS SCHOLARSHIP ONLINE (www.northcarolina.universitypressscholarship.com). (c) Copyright University of North Carolina Press, 2019. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in NCSO for personal use.date: 13 October 2019

The DNA of Biotechnology

The DNA of Biotechnology

Chapter:
(p.120) Chapter Six The DNA of Biotechnology
Source:
Prescription for Change
Author(s):

Michael Kinch

Publisher:
University of North Carolina Press
DOI:10.5149/northcarolina/9781469630625.003.0007

This chapter relates the birth of the biotechnology industry, whose origins can be traced back to the Spanish flu and which would later revolutionize both fundamental understanding of life as well as create new and improved products. We then relate how the birth of biotechnology transitioned from St Louis, Missouri to San Francisco largely based on the inspiration of one man and how this controversial revolution was almost upended by popular culture. Our story then turns to the creation of one of the earliest biotechnology companies, Genentech, and why the creation of this company was mired by criticism that cost two key inventors of DNA research the Nobel prize. Genentech and other companies would soon come to embrace a technology, known as monoclonal antibodies, which allowed for selective targeting analogous to the use of modern smart bombs and create its own conflicts with the rise of aggressive patenting. The opportunities arising from the technologies inspired many government and academic investigators to become entrepreneurs, foster companies such as MedImmune to develop revolutionary new therapies to prevent a major killer of premature infants, Respiratory Syncytial Virus (RSV).

Keywords:   Biotechnology, DNA, Monoclonal antibodies, Respiratory syncytial virus

North Carolina Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .